SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 936.93 |
| Enterprise Value ($M) | 784.06 |
| Book Value ($M) | 745.76 |
| Book Value / Share | 5.64 |
| Price / Book | 1.26 |
| NCAV ($M) | 674.42 |
| NCAV / Share | 5.10 |
| Price / NCAV | 1.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.37 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 20.73 |
| Current Ratio | 20.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 770.10 |
| Assets | 841.44 |
| Liabilities | 95.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 25.55 |
| Operating Income | -379.42 |
| Net Income | -341.97 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -300.32 |
| Cash from Investing | 257.63 |
| Cash from Financing | 34.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Price T Rowe Associates Inc /md/ | 7.00 | ||
| 13G/A | Casdin Capital, LLC | 5.99 | 17.30 | |
| 13G/A | Vanguard Group Inc | 8.64 | 2.56 | |
| 13G/A | BlackRock Inc. | 7.80 | 19.70 | |
| 13G/A | State Street Corp | 3.98 | -21.72 | |
| 13G/A | Fmr Llc | 2.43 | -69.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 178,520 | 958,608 | 18.62 | |
| 77,131 | 367,359 | 21.00 | |
| 237,930 | 698,233 | 34.08 | |
| 121,782 | 448,129 | 27.18 | |
| 177,183 | 456,118 | 38.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RANI – Rani Therapeutics Holdings, Inc. | RAPT – RAPT Therapeutics, Inc. |
| RCKT – Rocket Pharmaceuticals, Inc. | RNA – Avidity Biosciences, Inc. |
| RNAC – Cartesian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io